Clinical Trial Update: Detection of CSF Next Generation Sequencing in the Application of Brain Metastases From Lung Adenocarcinoma or Meningeal Metastasis

View source ↗

Summary

A clinical trial sponsored by Shandong Cancer Hospital and Institute is evaluating cerebrospinal fluid next-generation sequencing for detecting brain metastases…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Leptomeningeal Metastasis
• Lung Adenocarcinoma

Snippet

Sponsor: Shandong Cancer Hospital and Institute | Conditions: Recruitment | Status: UNKNOWN